Page last updated: 2024-10-23

bendroflumethiazide and Chondrocalcinosis

bendroflumethiazide has been researched along with Chondrocalcinosis in 1 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Chondrocalcinosis: Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Whelan, BR1
O'Shea, F1
McCarthy, G1

Other Studies

1 other study available for bendroflumethiazide and Chondrocalcinosis

ArticleYear
Pseudoneuropathic CPPD arthropathy: magnesium matters.
    Rheumatology (Oxford, England), 2008, Volume: 47, Issue:4

    Topics: Ankle Joint; Bendroflumethiazide; Chondrocalcinosis; Diuretics; Humans; Magnesium Deficiency; Male;

2008